• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Notes from the Field: Testing for Nonprescribed Fentanyl and Percentage of Positive Test Results Among Patients with Opioid Use Disorder - United States, 2019-2020.

作者信息

Niles Justin K, Gudin Jeffrey, Vivolo-Kantor Alana M, Gladden R Matthew, Mustaquim Desiree, Seth Puja, Kaufman Harvey W

出版信息

MMWR Morb Mortal Wkly Rep. 2021 Nov 26;70(47):1649-1651. doi: 10.15585/mmwr.mm7047a4.

DOI:10.15585/mmwr.mm7047a4
PMID:34818316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8612509/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4a/8612509/cc688d5b8f7e/mm7047a4-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4a/8612509/cc688d5b8f7e/mm7047a4-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db4a/8612509/cc688d5b8f7e/mm7047a4-F.jpg

相似文献

1
Notes from the Field: Testing for Nonprescribed Fentanyl and Percentage of Positive Test Results Among Patients with Opioid Use Disorder - United States, 2019-2020.实地记录：美国2019 - 2020年阿片类物质使用障碍患者中非处方芬太尼检测及阳性检测结果百分比
MMWR Morb Mortal Wkly Rep. 2021 Nov 26;70(47):1649-1651. doi: 10.15585/mmwr.mm7047a4.
2
Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.芬太尼在可卡因或甲基苯丙胺尿检阳性结果中的阳性率。
JAMA Netw Open. 2019 Apr 5;2(4):e192851. doi: 10.1001/jamanetworkopen.2019.2851.
3
Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database.从全国尿液药物检测数据库看丁丙诺啡治疗患者的多药物使用情况。
JAMA Netw Open. 2021 Sep 1;4(9):e2123019. doi: 10.1001/jamanetworkopen.2021.23019.
4
The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020.新冠疫情下的阿片类药物流行：2020 年的药物检测。
Popul Health Manag. 2021 Feb;24(S1):S43-S51. doi: 10.1089/pop.2020.0230. Epub 2020 Oct 8.
5
Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada.在加拿大安大略省接受阿片类激动剂治疗的患者中，COVID-19 大流行期间芬太尼使用增加的证据。
Int J Drug Policy. 2021 Apr;90:103088. doi: 10.1016/j.drugpo.2020.103088. Epub 2020 Dec 23.
6
Prevalence of recent fentanyl use among treated users of illicit opioids in England: based on piloted urine drug screens.英国经治滥用阿片类非法药物使用者中近期芬太尼使用情况的流行率：基于试点尿药物筛查结果。
Clin Toxicol (Phila). 2019 May;57(5):368-371. doi: 10.1080/15563650.2018.1527927. Epub 2018 Dec 16.
7
Prevalence of fentanyl exposure and knowledge regarding the risk of its use among emergency department patients with active opioid use history at an urban medical center in Baltimore, Maryland.马里兰州巴尔的摩市一家城市医疗中心有过阿片类药物使用史的急诊患者中，芬太尼暴露和对其使用风险认知的流行情况。
Clin Toxicol (Phila). 2020 Jun;58(6):460-465. doi: 10.1080/15563650.2019.1657583. Epub 2019 Sep 1.
8
Trends in opioid analgesic abuse and mortality in the United States.美国阿片类镇痛药滥用和死亡率的趋势。
N Engl J Med. 2015 Jan 15;372(3):241-8. doi: 10.1056/NEJMsa1406143.
9
Fentanyl exposure among patients seeking opioid treatment.阿片类药物治疗患者的芬太尼暴露。
J Subst Abuse Treat. 2019 Jan;96:23-25. doi: 10.1016/j.jsat.2018.10.007. Epub 2018 Oct 17.
10
Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder.芬太尼暴露和阿片类药物使用障碍患者开始治疗时的偏好。
Drug Alcohol Depend. 2019 Nov 1;204:107515. doi: 10.1016/j.drugalcdep.2019.06.017. Epub 2019 Aug 30.

引用本文的文献

1
Application of The Consolidated Framework for Implementation Research to inform understanding of barriers and facilitators to the implementation of opioid and naloxone training on college campuses.应用实施研究综合框架来增进对大学校园阿片类药物和纳洛酮培训实施过程中的障碍与促进因素的理解。
Implement Sci Commun. 2023 May 23;4(1):56. doi: 10.1186/s43058-023-00438-y.
2
Development and pilot evaluation of an educational session to support sparing opioid prescriptions to opioid naïve patients in a Canadian primary care setting.在加拿大初级保健环境中，开发并试点评估了一个教育课程，以支持对阿片类药物初治患者开出较少的阿片类药物处方。
Fam Pract. 2022 Nov 22;39(6):1024-1030. doi: 10.1093/fampra/cmac044.

本文引用的文献

1
Trends in Filled Naloxone Prescriptions Before and During the COVID-19 Pandemic in the United States.美国 COVID-19 大流行前后阿片类药物纳洛酮处方的变化趋势。
JAMA Health Forum. 2021 May 14;2(5):e210393. doi: 10.1001/jamahealthforum.2021.0393. eCollection 2021 May.
2
Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic.美国临床医生在 COVID-19 大流行期间利用扩大的授权开具丁丙诺啡治疗阿片类药物使用障碍处方的特征和相关性。
Drug Alcohol Depend. 2021 Aug 1;225:108783. doi: 10.1016/j.drugalcdep.2021.108783. Epub 2021 May 23.
3
Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019.
2013-2019 年美国药物和合成阿片类药物过量死亡的趋势和地理模式。
MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):202-207. doi: 10.15585/mmwr.mm7006a4.
4
Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic.美国在新冠疫情前后因心理健康、药物过量和暴力而前往急诊部就诊的趋势。
JAMA Psychiatry. 2021 Apr 1;78(4):372-379. doi: 10.1001/jamapsychiatry.2020.4402.
5
The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020.新冠疫情下的阿片类药物流行：2020 年的药物检测。
Popul Health Manag. 2021 Feb;24(S1):S43-S51. doi: 10.1089/pop.2020.0230. Epub 2020 Oct 8.
6
Analysis of Drug Test Results Before and After the US Declaration of a National Emergency Concerning the COVID-19 Outbreak.分析美国宣布新冠疫情为国家紧急状态前后的药物检测结果。
JAMA. 2020 Oct 27;324(16):1674-1677. doi: 10.1001/jama.2020.17694.